inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study. full covid-19 vaccination(at least after 2nd dose of tfda-approved vaccine 14 days)

inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study. full covid-19 vaccination(at least after 2nd dose of tfda-approved vaccine 14 days)

inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study. full covid-19 vaccination(at least after 2nd dose of tfda-approved vaccine 14 days) no planned antiviral drug usage(remdesivir, paxlovid, molnupiravir, etc) before enrollment

inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study. full covid-19 vaccination(at least after 2nd dose of tfda-approved vaccine 14 days) no planned antiviral drug usage(remdesivir, paxlovid, molnupiravir, etc) before enrollment

inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study.

inclusion criteria: age older than 20 years of age admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours available informed consent of this study.

inclusion criteria: 1. age older than 20 years of age 2. admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) 3. disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours 4. available informed consent of this study.

inclusion criteria: 1. age older than 20 years of age 2. admission with a confirmed positive test for sars-cov-2 infection by reverse transcription polymerase chain reaction (rt- pcr) 3. disease onset (start of covid-19 symptom and pcr test) for ≤ 120 hours 4. available informed consent of this study.